Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06412536 · ClinicalTrials.gov registry record
Triage Survey for Cardiovascular, Obesity, and Related Endocrine Trial Eligibility
A clinical trial of Obesity and Cardiovascular Diseases, sponsored by Brooklyn Clinical Research.
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 1
- Study location
NCT06412536: Recruiting study of Obesity and Cardiovascular Diseases, sponsored by Brooklyn Clinical Research.
NCT06412536 is a study of Obesity and Cardiovascular Diseases that is actively recruiting participants, run by Brooklyn Clinical Research. The registered enrollment target is 10,000 participants, above the 809-participant average among 1,053 other Obesity trials with a reported enrollment target (1136% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06412536, a study of Obesity and Cardiovascular Diseases, is actively recruiting participants, sponsored by Brooklyn Clinical Research.
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 1
- Study location
Study Summary
SWIFT-CORE-101 is a single site survey study designed to assess potential participants' eligibility to screen for industry-sponsored clinical trials. A physician will oversee the informed consent process, after which participants will be surveyed on demographics, medical history, comorbidities, and current symptoms. Site staff may collect vital signs, urine drug screens, blood draws, and urine pregnancy tests. A doctor will review medical history with the participant to determine study suitability via clinical interview. The doctor may reach out to the patient's current treating physicians and pharmacies to determine eligibility for clinical trials.
Primary Outcome
Number of participants who are interested in industry-sponsored clinical research in each of the following therapeutic areas: cardiovascular, obesity, and endocrine.
Conditions Studied
Interventions
- OTHER Blood work
Study Locations (1)
New York
- Brooklyn Clinical Research - Brooklyn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2024-05-30 |
| Est. Completion | 2029-04-17 |
What NCT06412536 shows while recruiting
NCT06412536 is an observational study that tracks outcomes without assigning an intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus, above the 809-participant average among 1,053 other Obesity trials with a reported enrollment target (1136% higher).
The record links to 5 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Blood work is the first listed.
NCT06412536 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06412536 about?
NCT06412536 is a clinical study titled "Triage Survey for Cardiovascular, Obesity, and Related Endocrine Trial Eligibility". SWIFT-CORE-101 is a single site survey study designed to assess potential participants' eligibility to screen for industry-sponsored clinical trials. A physician will oversee the informed consent process, after which participants will be surveyed on demographics, medical history, comorbidities, and ...
What is the current status of trial NCT06412536?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2024-05-30. Estimated completion is 2029-04-17.
What conditions does trial NCT06412536 study?
This clinical trial studies the following conditions: Obesity, Cardiovascular Diseases, PreDiabetes, Metabolic Syndrome, Diabetes Type 2.
What interventions are being tested in trial NCT06412536?
The interventions under investigation include: Blood work (OTHER).
Who is sponsoring clinical trial NCT06412536?
This trial is sponsored by Brooklyn Clinical Research, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06412536 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06412536's enrollment target sits among peer trials
10,000 8th of 1053 higher than 1,046 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00160771 · 10,000 participants
Biomechanics/Motion Analysis Laboratory Data Bank
- NCT00896935 · 10,000 participants
Arizona Cancer Center Biospecimen Repository
- NCT00898235 · 10,000 participants
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
- NCT00992303 · 10,000 participants
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI